Valuation: Guerbet

Market Cap 112M 128M 104M 97M 182M 12.09B 186M 1.25B 482M 5.98B 481M 471M 20.72B P/E 2026 *
-250x
P/E 2027 * 5.54x
Enterprise Value 406M 463M 374M 350M 657M 43.67B 671M 4.5B 1.74B 21.58B 1.74B 1.7B 74.84B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.49x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.93%
1 day-1.00%
1 week-3.36%
Current month-16.73%
1 month-14.98%
3 months-9.08%
6 months-36.72%
Current year-37.69%
1 week 8.73
Extreme 8.73
9.37
1 month 8.73
Extreme 8.73
10.92
Current year 8.01
Extreme 8.01
15.12
1 year 8.01
Extreme 8.01
23.7
3 years 8.01
Extreme 8.01
40.25
5 years 8.01
Extreme 8.01
45.65
10 years 8.01
Extreme 8.01
90.64
Manager TitleAgeSince
Chief Executive Officer - 01/02/2026
Chief Executive Officer - 21/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 28/05/2015
Director/Board Member 49 18/05/2017
Director/Board Member 51 21/11/2023
Date Insider Type Main position Quantity % Market Cap.
11-12Buy

Director

90 0.0007%
11-12Buy

Director

1,100 0.0087%
09/10/25Buy

Director

200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%-3.36%-57.97%-47.89% 128M
-3.22%-5.07%-23.38%-29.69% 11.84B
-6.66%-12.39%+66.20%+7.33% 4.59B
+0.10%+1.91%+54.44%+95.18% 1.2B
-4.01%-5.67%-39.23%-67.33% 1.14B
-3.99%-11.87%-41.79%-51.14% 1.04B
-3.49%-7.80%-44.75% - 871M
-3.51%-14.31%+151.08%+153.94% 600M
+7.58%+13.77% - - 376M
+2.86%+3.06%-57.14%+209.17% 255M
Average -1.53%-2.82%+0.83%+33.70% 2.2B
Weighted average by Cap. -3.58%-5.00%+1.58%-9.32%

Financials

2026 *2027 *
Net sales 754M 860M 695M 650M 1.22B 81.1B 1.25B 8.35B 3.23B 40.08B 3.23B 3.16B 139B 796M 908M 734M 687M 1.29B 85.66B 1.32B 8.82B 3.41B 42.33B 3.41B 3.34B 147B
Net income -1.62M -1.84M -1.49M -1.4M -2.62M -174M -2.67M -17.92M -6.93M -85.99M -6.93M -6.77M -298M 29.08M 33.17M 26.81M 25.1M 47.06M 3.13B 48.03M 322M 125M 1.55B 125M 122M 5.36B
Net Debt 294M 335M 271M 253M 475M 31.58B 485M 3.25B 1.26B 15.61B 1.26B 1.23B 54.12B 277M 316M 256M 239M 449M 29.84B 458M 3.07B 1.19B 14.75B 1.19B 1.16B 51.14B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
26/06/26 €8.910 -1.00% 44,462
25/06/26 €9.000 -1.96% 58,556
24/06/26 €9.180 -0.54% 8,673
23/06/26 €9.230 +1.43% 11,225
22/06/26 €9.100 -1.30% 7,788
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
8.910EUR
Average target price
11.60EUR
Spread / Average Target
+30.19%

Quarterly revenue - Rate of surprise